Evaluating CT Colonography for Colonic Cancer Diagnosis in Older Patients
Author Information
Author(s): Steve Halligan, Richard J Lilford, Jane Wardle, Dion Morton, Pauline Rogers, Katherine Wooldrage, Rob Edwards, Reshma Kanani, Urvi Shah, Wendy Atkin
Primary Institution: University College Hospital London
Hypothesis
The SIGGAR trial aims to determine the diagnostic efficacy, acceptability, and economic costs associated with CT colonography compared to standard tests like colonoscopy and barium enema.
Conclusion
The SIGGAR trial is designed to compare the effectiveness and costs of CT colonography against traditional methods for diagnosing colorectal cancer.
Supporting Evidence
- CT colonography has high average sensitivity and specificity for diagnosing colorectal neoplasia.
- Colonoscopy is technically difficult and resource-intensive, especially for elderly patients.
- Barium enema is safer but has reduced sensitivity for cancer detection.
- CT colonography may combine high sensitivity for cancer with safety and patient acceptability.
Takeaway
This study is looking at whether a new type of scan called CT colonography is better and safer than the usual tests for finding colon cancer in older people.
Methodology
The trial is a multi-centre randomised comparison of CT colonography versus standard investigation (barium enema or colonoscopy), focusing on diagnostic efficacy and associated costs.
Potential Biases
Potential bias may arise from the selection of centres based on interest and capability, which could affect generalizability.
Limitations
The trial's initial sample size assumptions were found to be overestimates, leading to an increase in the required sample size.
Participant Demographics
Eligible participants are aged 55 years or older with symptoms suggestive of colorectal cancer.
Statistical Information
Confidence Interval
95% CI, 91% to 99%
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website